Correlation Between Marriott International and CanSino Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Marriott International and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marriott International and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marriott International and CanSino Biologics, you can compare the effects of market volatilities on Marriott International and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marriott International with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marriott International and CanSino Biologics.

Diversification Opportunities for Marriott International and CanSino Biologics

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Marriott and CanSino is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Marriott International and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Marriott International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marriott International are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Marriott International i.e., Marriott International and CanSino Biologics go up and down completely randomly.

Pair Corralation between Marriott International and CanSino Biologics

Assuming the 90 days horizon Marriott International is expected to generate 1.17 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, Marriott International is 2.9 times less risky than CanSino Biologics. It trades about 0.1 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  291.00  in CanSino Biologics on September 27, 2024 and sell it today you would earn a total of  75.00  from holding CanSino Biologics or generate 25.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Marriott International  vs.  CanSino Biologics

 Performance 
       Timeline  
Marriott International 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Marriott International are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Marriott International reported solid returns over the last few months and may actually be approaching a breakup point.
CanSino Biologics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Marriott International and CanSino Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Marriott International and CanSino Biologics

The main advantage of trading using opposite Marriott International and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marriott International position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.
The idea behind Marriott International and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk